Other health services
OXYFLOW TESTLAB AS
Revenue 2024
NOK 321,000
Operating profit
NOK 50,000
Equity
NOK 74,000
Incorporated
2021
Share capital
NOK 30,000
Key figures · 2024
Current ratio
1.74
Equity ratio
14.2%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 15.5% | |
| Net margin (%%) | 2.9% | |
| Return on assets (%%) | 9.6% | |
| Likviditet | ||
| Current ratio | 1.74 | |
| Working capital | 26k | |
| Soliditet | ||
| Equity ratio (%%) | 14.2% | |
| Debt-to-equity ratio | 6.04 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.